- tags:cornea
Pipeline
New findings support Brightstar Therapeutics' corneal allograft for LSCD
Pilot study investigates use of BrightMEM as an alternative form of corneal transplantation involving Descemet’s membrane.
Pipeline
Glaukos reports phase 3 topline data on Epioxa for keratoconus
Findings will support an anticipated NDA submission for the second-generation iLink therapy by the end of 2024.
Research
Long-term corneal endothelial changes noted after COVID
Corneal endothelial cell density and hexagonality negatively impacted ~5 months after COVID-19 infection.
Research
Study identifies key variables for keratoconus progression risk
New parameter may be the most significant indicator for corneal thinning and Max-K progression.
Research
Ectasia progression may diminish with epi-off CXL
New study shares findings on impact of Epi-off collagen cross-linking on keratoconus progression.
Research
Which factors are most influential in Fuchs' visual function?
Observational study explored possible relationships between visual function and FECD.
Events
KOLs eye the future of genetic engineering and cell transplantation
Industry leaders from four leading ophthalmic companies debut the latest clinical developments in cell-based therapeutics.
Pipeline
Refractive tech startup TECLens gets J&J investment
Private medical device company’s corneal cross-linking technology operates as a non-invasive, in-office treatment for keratoconus and progressive pediatric myopia.
Research
Fuch's dystrophy may be accelerated among certain patient demographics
Study investigates link between FECD and demographic factors such as BMI.
Events
Experts weigh in on key trends in anterior segment innovations
Ophthalmic leaders cover market opportunities, bridging the gap between physicians and industry, as well as premium patient outcomes for the future.
Events
Cornea and contact lens skills symposium kicks off this September
CLASS 2024 will debut for the first time in the United States with a jam-packed agenda, including CE opportunities.
Research
Thermal imaging device detects DED via eye temperature monitoring
University of Waterloo spinoff has developed a novel system designed to rapidly and non-invasively measure the ocular surface and diagnose dry eye.
Research
Could insulin eye drops provide corneal healing?
Researchers share new findings on the effectiveness of insulin therapy for neurotrophic keratitis.
Pipeline
FDA grants Breakthrough Therapy Designation, RMAT to Aurion's CED cell therapy
AURN001 is now the first allogeneic cell therapy to be granted two designations for corneal edema secondary to CED.
Research
Eversight and LighTopTech partner on ophthalmic imaging advancements
Global nonprofit eye bank will use the tech company’s proprietary OCX imaging system for research into retinal disease and retinal-related vision loss.
Research
RKI drops may protect endothelial cells post-cataract surgery
Topical rho kinase inhibitors potentially reduce endothelial cell loss following cataract surgery.
Pipeline
Oculis reports positive phase 2b topline data on licaminlimab for DED
OSC-02 eye drop demonstrates rapid treatment effect on corneal inflammation as early as 2 weeks of treatment.
Products
Quantel Medical introduces lightweight handheld pachymeter
Weighing in at just 60 grams, the POCKET III is designed to accurately measure corneal thickness with an extended range.
Pipeline
Cell therapy dosing concludes for Emmecell's corneal edema trial
Minimally-invasive cell therapy has been designed to repopulate dysfunctional corneal endothelial cells, potentially eliminating the need for transplantation.
Research